Replacing two cycles of intensive chemotherapy with Blincyto raised four-year event-free survival to 83% from 70.3% in children with high-risk B-cell ALL, with far fewer infections.
|Articles|February 20, 2019
Important Resources
A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.
Advertisement
Managing the financial aspects of care can be overwhelming for patients and caregivers as they apply for health insurance, file insurance claims and make co-payments. The Leukemia & Lymphoma Society provides resources to help people who are facing these challenges.
- Copay assistance: Financial support eases the cost of copayments or insurance premiums for prescription drugs.
- Susan Lang Pay-It Forward Patient Travel Assistance: Blood cancer patients who have significant financial need may qualify to receive financial assistance for ground transportation, air travel and lodging expenses related to their care.
- Other resources: Additional information may lead to more assistance with prescription drug and stem cell transplantation costs.
- Most drug companies have programs for qualifying patients to mitigate the cost of cancer drugs.
The
Advertisement
Related to this article
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
The FDA approval is based on the phase 3 BRUIN CLL-313 trial, in which 94% of patients responded to Jaypirca compared with 81% who received chemoimmunotherapy.
Advertisement
Advertisement
Trending on CURE
1
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis
2
The Cancer Search Bar: Top Lung Cancer Surgery Questions Answered
3
Rina-S Shows 45.9% Response Rate in Platinum-Resistant Ovarian Cancer
4
Dana-Farber Expert Explains Rina-S Data in Platinum-Resistant Ovarian Cancer
5